Zynerba Pharmaceuticals, Inc. (ZYNE): Price and Financial Metrics

Zynerba Pharmaceuticals, Inc. (ZYNE)

Today's Latest Price: $4.49 USD

0.02 (0.45%)

Updated Dec 2 4:00pm

Add ZYNE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZYNE Stock Summary

  • Zynerba Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.07% of US listed stocks.
  • With a price/sales ratio of 1,661.62, Zynerba Pharmaceuticals Inc has a higher such ratio than 99.79% of stocks in our set.
  • The volatility of Zynerba Pharmaceuticals Inc's share price is greater than that of 93.47% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Zynerba Pharmaceuticals Inc, a group of peers worth examining would be BPMX, RVNC, ADVM, PSTI, and PRTA.
  • Visit ZYNE's SEC page to see the company's official filings. To visit the company's web site, go to www.zynerba.com.

ZYNE Stock Price Chart Interactive Chart >

Price chart for ZYNE

ZYNE Price/Volume Stats

Current price $4.49 52-week high $7.45
Prev. close $4.47 52-week low $2.55
Day low $4.20 Volume 444,062
Day high $4.55 Avg. volume 912,808
50-day MA $3.73 Dividend yield N/A
200-day MA $4.06 Market Cap 132.18M

Zynerba Pharmaceuticals, Inc. (ZYNE) Company Bio

Zynerba Pharmaceuticals is a specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company was founded in 2007 and is based in Devon, Pennsylvania.

ZYNE Latest News Stream

Event/Time News Detail
Loading, please wait...

ZYNE Latest Social Stream

Loading social stream, please wait...

View Full ZYNE Social Stream

Latest ZYNE News From Around the Web

Below are the latest news stories about Zynerba Pharmaceuticals Inc that investors may wish to consider to help them evaluate ZYNE as an investment opportunity.

Zynerba Pharmaceuticals (ZYNE) Investor Presentation - Slideshow

The following slide deck was published by Zynerba Pharmaceuticals, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

Zynerba's cannabidiol an Orphan drug for a rare chromosomal disorder

The FDA has granted Orphan drug status for Zynerba's ([[ZYNE]] +6.2%) cannabidiol as a treatment of 22q.11.2 deletion syndrome, according to a post to the agency's website.Also known as DiGeorge syndrome, the syndrome is caused when a small part of chromosome 22 is missing, resulting in the poor development of several...

Seeking Alpha | September 17, 2020

Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights

DEVON, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal…

GlobeNewswire | August 10, 2020

Cannabis Stock Gainers And Losers From August 4, 2020

Gainers: MGC Pharmaceuticals (OTC: MGCLF ) shares closed up 72.5% at $0.04 Heritage Cannabis Holding (OTC: HERTF ) shares closed up 20.97% at $0.08 Tilray (NASDAQ: TLRY ) shares closed up 17.09% at $8.70 InMed Pharmaceuticals (OTC: IMLFF ) shares closed up 13.81% at $4.78 EnWave (OTC: NWVCF ) shares closed up 12.9% at $0.80 CV Sciences (OTC: CVSI ) shares closed up 11.61% at $0.74 Halo Labs (OTC: AGEEF ) shares closed up 9.76% at $0.09 Alcanna (OTC: LQSIF ) shares closed up 8.99% at $3.03 Zynerba Pharmaceuticals (NASDAQ: ZYNE ) shares closed up … Full story available on Benzinga.com

Benzinga | August 4, 2020

Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know

Zynerba Pharmaceuticals (ZYNE) closed the most recent trading day at $3.79, moving +1.34% from the previous trading session.

Yahoo | July 29, 2020

Read More 'ZYNE' Stories Here

ZYNE Price Returns

1-mo 29.02%
3-mo 20.70%
6-mo -17.01%
1-year -25.54%
3-year -69.20%
5-year -65.35%
YTD -25.66%
2019 103.37%
2018 -76.28%
2017 -19.69%
2016 54.82%
2015 N/A

Continue Researching ZYNE

Here are a few links from around the web to help you further your research on Zynerba Pharmaceuticals Inc's stock as an investment opportunity:

Zynerba Pharmaceuticals Inc (ZYNE) Stock Price | Nasdaq
Zynerba Pharmaceuticals Inc (ZYNE) Stock Quote, History and News - Yahoo Finance
Zynerba Pharmaceuticals Inc (ZYNE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0065 seconds.